Objective Initiation of DMARD-therapy in the 'window of opportunity'is thought to result in a
more effective modification of the processes underlying rheumatoid arthritis (RA). We …

Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis …

Die frühzeitige Behandlung der rheumatoiden Arthritis (RA) ist von zentraler Bedeutung für
den gesamten weiteren Krankheitsverlauf. Das Ziel der Leitlinie ist, die Versorgung der …

Objective Anticitrullinated protein antibodies (ACPA) are a major risk factor for bone loss in
rheumatoid arthritis (RA). We have recently shown that ACPA directly induce bone loss by …

Objective To assess the efficacy of etanercept in the treatment of early active nonsteroidal
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA) …

Background We assessed the effects of reduction and withdrawal of treatment in patients
with rheumatoid arthritis who had a remission while receiving etanercept-plus-methotrexate …

Background To assess whether, in the real world of three early arthritis clinics, early referral
could allow the best outcome, ie, remission, to be reached, and whether reaching the …

Представлены новые рекомендации Общероссийской общественной организации
«Ассоциация ревматологов России»(АРР) по лечению ревматоидного артрита (РА) …

Objective To perform a systematic literature review (SLR) on pharmacological and non-
pharmacological treatments, in order to inform the European League Against Rheumatism …

Objectives A treat-to-target (T2T) strategy has been shown to be superior to usual care in
rheumatoid arthritis (RA), but the optimal target remains unknown. Targets are based on a …